Endokrinologi

Klinik Bandung
Scientific Programme
Ke- XXI Tahun 2024 Jumat, 9 Agustus 2024
Bridging to Get Dismetabolic (Workshop LLL)
and Endocrine Disorder

9 Agustus 2024 (Workshop LLL)

Waktu Topik Pembicara
07.30 - 07.55 Registrasi Ulang Peserta
07.55 - 08.00 Pembukaan
Workshop 1
08.00 - 12.00
Screening, Diagnosis and Assessment of Malnutrition
Dr. dr. Nanny Natalia Mulyani
Nutritional Screening and
08.00 - 08.40 Soetedjo, Sp.PD-KEMD., M.Kes.,
Assessment
DCN., FINASIM
08.40 - 08.55 Coffee Break
dr Hartono.,SpKKLP., MM.,
08.55 - 09.35 Body Composition
Ph.D.,DCN
dr. Jonny, SpPD-KGH, MKes, MM,
09.35 - 10.15 Energy Balance
DCN
10.15 - 11.35 Cases & Test
11.35 - 13.00 Shalat Jumat and Lunch
Workshop 2
13.00 - 17.15
Approach to Oral and Eteral Nutrition in Adult
Dr. dr. Nanny Natalia Mulyani
Indications, Contraindications, Complications and
Soetedjo, Sp.PD-KEMD., M.Kes.,
Monitoring of EN
13.00 -13.40 DCN., FINASIM
dr Hartono.,SpKKLP., MM.,
13.40 - 14.20 Hospital Diet and Oral Nutritional Suplement (Sip Feeding)
Ph.D.,DCN
dr Hartono.,SpKKLP., MM.,
14.20 - 15.00 Technique of EN
Ph.D.,DCN
15.00 - 15.15 Coffee Break
dr. Jonny, SpPD-KGH, MKes, MM,
15.15 - 15.55 Formulae for EN DCN
15.55 - 17.15 Cases & Test
 Endokrinologi
Klinik Bandung
Scientific Programme
Ke- XXI Tahun 2024 Sabtu, 10 Agustus 2024
Bridging to Get Dismetabolic (Hari ke 1)
and Endocrine Disorder

Waktu (WIB) Ballroom

08.30 - 09.00 Pembukaan dan Sambutan
08.30 - 08.35 MC Opening
08.35 -08.40 Menyanyikan Lagu Indonesia Raya
08.40 - 08.45 Menyanyikan Mars Perkeni
08.45 - 08.50 Sambutan Ketua Pelaksana dan Perkeni Cabang Bandung
08.50 -08.55 Video Opening
08.55 - 09.00 Foto Bersama
Plennary
Role of hypertrigliceride in dismetabolic energy
09.00 - 09.30
Moderator : Prof. DR. Dr. Hikmat Permana, Sp.PD-KEMD., FINASIM

Pembicara : Prof. Dr.med. Tri Hanggono Achmad, dr

Symposium 1
09.30 - 10.20 Optimal Integration of Lipid Goals and Cardiovascular Treatments
Moderator: dr.
dr.Octo
OctoIndradjaja,
Indradjaja, Sp.PD-KEMD
Sp.PD-KEMD
09.30 - 09.50 Lipid Goals and Optimal Timing of Proven Cardiovascular Disease Treatments
Dr. dr. Nanny Natalia Mulyani Soetedjo, Sp.PD-KEMD., M.Kes., DCN., FINASIM
09.50 -10.10 Reasons for Integrating β-Blockers into Major Antihypertensive Drug Regimens
dr Nuraini Yasmin K SpPD.,SpJP
10.10 -10.20 Diskusi
10.20 - 10.30 Coffee Break
Pre Lunch Sympo 1
10.30 - 11.20 Pathophysiology and Risk Factors: Understanding the Diabetes Continuum
Moderator : dr.
dr Augusta YL Arifin,
Octo Indradjaja, Sp.PD-KEMD, FINASIM
Sp.PD-KEMD
10.30 - 10.50 Pharmacological Approaches to Prediabetes: The Benefit of Metformin Therapy
dr. Ervita Ritonga, Sp.PD-KEMD., M.Kes
The importance of achieving HbA1C control in the first year of treatment, How and What
10.50 - 11.10
are the Benefits?
Prof. DR. Dr. Hikmat Permana, Sp.PD-KEMD., FINASIM
11.10 - 11.20 Diskusi
Lunch Sympo 1
11.20 -12.10 Optimizing Renoprotective Strategies: Personalized Approaches in CKD
Moderator : Prof. DR. Dr. Hikmat Permana, Sp.PD-KEMD., FINASIM
11.20 - 11.40 Optimal Patient Selection and Risk Stratification for SGLT2 Inhibitor Therapy in T2D
Prof. Dr. dr. Ketut Suastika, Sp.PD-KEMD
11.40 - 12.00 Balancing RAASi Therapy in CKD: Introducing The Role of SZC
Prof. Dr. Rudi Supriyadi, dr. Mkes, Sp.PD(KGH), FINASIM
12.00 - 12.10 Diskusi
12.10 - 13.00 Ishoma
 Endokrinologi
Klinik Bandung
Scientific Programme
Ke- XXI Tahun 2024 Sabtu, 10 Agustus 2024
Bridging to Get Dismetabolic (Hari ke 1)
and Endocrine Disorder

Symposium 2
13.00 - 13.50 Incretin-Based Therapy: from clinical data to clinical practice
Moderator : dr.
dr Augusta YL Arifin,
Octo Indradjaja, Sp.PD-KEMD, FINASIM
Sp.PD-KEMD
Evolution of T2DM treatment beyond glycemic control: benefit of Dulaglutide in cardio-
13.00 - 13.20
renal-neuro protection
dr Maya Kusumawati, Sp.PD-KEMD, FINASIM
13.20 - 13.40 Achieving T2D Therapy Target: Sitagliptin Across Diverse Patient Profiles
dr. Ervita Ritonga, Sp.PD-KEMD., M.Kes
13.40 - 13.50 Diskusi
Symposium 3
13.50 - 14.40 How to treat and screen in Type 2 Diabetes to prevent the complication
Moderator : Prof.
dr Augusta YL Arifin,
Dr. dr. Ketut Sp.PD-KEMD,
Suastika, FINASIM
Sp.PD-KEMD
Glycemic Control, The Cornerstone of The Quality of Life of People Living with Type 2
13.50 - 14.10
Diabetes: Focus on Sitagliptin
Prof. DR. Dr. Hikmat Permana, Sp.PD-KEMD., FINASIM
14.10 - 14.30 Lipoprotein(a): A less understood but critical risk factor for heart and metabolic disease
Prof. Dr. dr. Sidartawan Soegondo, Sp.PD-KEMD, FINASIM, FACE
14.30 - 14.40 Diskusi
Workshop 1
Urgency Dyslipidemia Management :
Worskhop 2
15.00 - 16.00 The Role of Trigliseride Rich
Recent Advances in Injectable Therapy
Lipoprotein & Non HDL

What is the new target in Dyslipidemia Practical use of IdegAsp in special

after LDL? populations
15.00 - 15.20
Prof. DR. Dr. Hikmat Permana, Sp.PD- dr Augusta YL Arifin, Sp.PD-KEMD,
dr. Yumilia Hoo, Sp.PD-KEMD
KEMD., FINASIM FINASIM

When to treat trigliceride in Dyslipidemia? Is GLP-1 RA Only for People with Type 2
15.20 - 15.40 dr Maya Kusumawati, Sp.PD-KEMD, Diabetes and Obesity?
FINASIM dr. Luse Sp.PD-KEMD, FINASIM

Case Presentation :
Case Presentation :
15.40 - 16.00 dr. Muhammad Iman Pratama Putra,
dr. Marshell Tendean, Sp.PD
Sp.PD
16.00 - 16.10 Diskusi Diskusi
 Endokrinologi
Klinik Bandung
Scientific Programme
Ke- XXI Tahun 2024 Minggu, 11 Agustus 2024
Bridging to Get Dismetabolic (Hari ke 2)
and Endocrine Disorder

TIME Ballroom
Morning Cases
08.30 - 09.30
What's New from AOTA 2024
Moderator: dr Maya Kusumawati, Sp.PD-KEMD, FINASIM
08.30 - 08.50 Long-term thiamazole and levothyroxine intensify patients quality of life
Prof. DR. Dr. Hikmat Permana Sp.PD-KEMD., FINASIM
08.50 - 09.10 The Impact of Thyroid Disorder on Cardiovascular disease : Cause or effect?
Dr. dr. Nanny Natalia Mulyani Soetedjo, Sp.PD-KEMD., M.Kes., DCN., FINASIM
09.10 - 09.30 Diskusi
Symposium 4
09.30 - 10.20 Maximizing Co-formulation Insulin to help T2DM patients reaching goals
Moderator : Prof. DR. Dr. Hikmat Permana Sp.PD-KEMD., FINASIM
09.30 - 09.50 Safety of Co-formulation insulin - learning from real world evidence study
dr. Yumilia Hoo, Sp.PD-KEMD
09.50 - 10.10 Practical use and clinical reccomendation, how to use Co-formulation insulin in daily
Dr. dr. Nanny Natalia Mulyani Soetedjo, Sp.PD-KEMD., M.Kes., DCN., FINASIM
10.10 - 10.20 Diskusi
10.20 -10.30 Coffee Break
Pre Lunch Sympo 2
10.30 - 11.20 Is GLP-1 RA Semaglutide Once-Weekly A New Kid(ney) on The Block?
Moderator: dr. Yumilia Hoo, Sp.PD-KEMD
10.30 - 10.50 Multifactorical Approach in Managing People with Type 2 Diabetes
dr. Octo Indradjaja, Sp.PD-KEMD
New Data from FLOW Trial: What Can We Learn About Semaglutide for People with
10.50 -11.10 Diabetic Kidney Disease?
dr Maria Riastuti Sp.PD KGH
11.10-11.20 Diskusi
Lunch Sympo 2
11.20 - 12.10 Cardio-Kidney-Metabolic Continuum in T2D
Moderator : dr Maya Kusumawati, Sp.PD-KEMD, FINASIM
11.20 - 11.40 Personalized management for T2D patients using current proven therapy
Dr. dr. Nanny Natalia Mulyani Soetedjo, Sp.PD-KEMD., M.Kes., DCN., FINASIM
11.40 - 12.00 What’s good looks like in the management of our T2D patients - the renal point of view
Prof. Dr. Rudi Supriyadi, dr. Mkes, Sp.PD(KGH), FINASIM
12.00 - 12.10 Diskusi
12.10 - 13.00 Ishoma
 Endokrinologi
Klinik Bandung
Scientific Programme
Ke- XXI Tahun 2024 Minggu, 11 Agustus 2024
Bridging to Get Dismetabolic (Hari ke 2)
and Endocrine Disorder

Symposium 5
13.00 - 13.50
Share Experience with FRC Iglar-Lixi
Moderator : dr. Luse Sp.PD-KEMD, FINASIM
13.00 - 13.20 Fixed ratio combination in new guideline for type 2 diabetes
Prof. DR. Dr. Hikmat Permana, Sp.PD-KEMD., FINASIM
13.20 - 13.40 Case Sharing Patients with FRC
dr. Ervita Ritonga, Sp.PD-KEMD., M.Kes
13.40 - 13.50 Diskusi
Symposium 6
13.50 - 15.00 Let's talk about Adrenal
Moderator : dr Maya Kusumawati, Sp.PD-KEMD, FINASIM
13.50 - 14.10 How to treat insufficiency adrenal in critical illness
Dr. dr. Nanny Natalia Mulyani Soetedjo, Sp.PD-KEMD., M.Kes., DCN., FINASIM
Case Sharing

dr. Enung Cahya Nurul, Sp.PD

14.10 - 14.50
dr. Irma Febrina, Sp.PD
dr. Affan Ahmadi, Sp.PD
14.50 - 15.00 Diskusi
15.00 - 15.15 Closing
15.00 - 15.05 Closing Statement
15.05 - 15.15 Foto Bersama